However, addition of JSH-23 (20 μM) significantly reduced the levels of secreted IL-8 in all treatment conditions, indicating that secretion of IL-8 is dependent on active NF-κB-signaling in MDA-MB-231 breast cancer cells. This evidence concerns the gene NFKB1 and breast carcinoma.